Kowalski Greg M, De Souza David P, Risis Steve, Burch Micah L, Hamley Steven, Kloehn Joachim, Selathurai Ahrathy, Lee-Young Robert S, Tull Dedreia, O'Callaghan Sean, McConville Malcolm J, Bruce Clinton R
Centre for Physical Activity and Nutrition Research, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria 3125, Australia.
Metabolomics Australia, Department of Biochemistry and Molecular Biology, Bio21 Institute of Molecular Science and Biotechnology, University of Melbourne, Parkville, Victoria 3010, Australia.
Biochem Biophys Res Commun. 2015 Aug 7;463(4):818-24. doi: 10.1016/j.bbrc.2015.06.019. Epub 2015 Jun 15.
Cardiac metabolism is thought to be altered in insulin resistance and type 2 diabetes (T2D). Our understanding of the regulation of cardiac substrate metabolism and insulin sensitivity has largely been derived from ex vivo preparations which are not subject to the same metabolic regulation as in the intact heart in vivo. Studies are therefore required to examine in vivo cardiac glucose metabolism under physiologically relevant conditions.
To determine the temporal pattern of the development of cardiac insulin resistance and to compare with dynamic approaches to interrogate cardiac glucose and intermediary metabolism in vivo.
Studies were conducted to determine the evolution of cardiac insulin resistance in C57Bl/6 mice fed a high-fat diet (HFD) for between 1 and 16 weeks. Dynamic in vivo cardiac glucose metabolism was determined following oral administration of [U-(13)C] glucose. Hearts were collected after 15 and 60 min and flux profiling was determined by measuring (13)C mass isotopomers in glycolytic and tricarboxylic acid (TCA) cycle intermediates. Cardiac insulin resistance, determined by euglycemic-hyperinsulinemic clamp, was evident after 3 weeks of HFD. Despite the presence of insulin resistance, in vivo cardiac glucose metabolism following oral glucose administration was not compromised in HFD mice. This contrasts our recent findings in skeletal muscle, where TCA cycle activity was reduced in mice fed a HFD. Similar to our report in muscle, glucose derived pyruvate entry into the TCA cycle in the heart was almost exclusively via pyruvate dehydrogenase, with pyruvate carboxylase mediated anaplerosis being negligible after oral glucose administration.
Under experimental conditions which closely mimic the postprandial state, the insulin resistant mouse heart retains the ability to stimulate glucose metabolism.
心脏代谢被认为在胰岛素抵抗和2型糖尿病(T2D)中会发生改变。我们对心脏底物代谢调节和胰岛素敏感性的理解很大程度上来自体外实验,而这些实验并不受体内完整心脏相同代谢调节的影响。因此,需要进行研究以检查生理相关条件下的体内心脏葡萄糖代谢。
确定心脏胰岛素抵抗发展的时间模式,并与体内研究心脏葡萄糖和中间代谢的动态方法进行比较。
进行研究以确定喂食高脂饮食(HFD)1至16周的C57Bl/6小鼠心脏胰岛素抵抗的演变。口服[U-(13)C]葡萄糖后测定体内心脏葡萄糖代谢动态。在15分钟和60分钟后收集心脏,并通过测量糖酵解和三羧酸(TCA)循环中间体中的(13)C质量同位素异构体来确定通量分析。通过正常血糖-高胰岛素钳夹法测定的心脏胰岛素抵抗在高脂饮食3周后明显。尽管存在胰岛素抵抗,但高脂饮食小鼠口服葡萄糖后的体内心脏葡萄糖代谢并未受到损害。这与我们最近在骨骼肌中的发现形成对比,在骨骼肌中,喂食高脂饮食的小鼠三羧酸循环活性降低。与我们在肌肉中的报告相似,心脏中葡萄糖衍生的丙酮酸进入三羧酸循环几乎完全通过丙酮酸脱氢酶,口服葡萄糖后丙酮酸羧化酶介导的回补作用可忽略不计。
在紧密模拟餐后状态的实验条件下,胰岛素抵抗的小鼠心脏保留了刺激葡萄糖代谢的能力。